Log in

Relevant bibliographies by topics / Antifungal antibiotic

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Antifungal antibiotic'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antifungal antibiotic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antifungal antibiotic"

1

Jingjing, Sun, Zhang Yanshu, Liu Yu, et al. "Factors related to antibiotic-associated diarrhea in patients in the intensive care unit receiving antifungals: a single-center retrospective study." Journal of International Medical Research 47, no. 5 (2019): 2067–76. http://dx.doi.org/10.1177/0300060519836305.

Full text

Abstract:

Objective To analyze factors related to antibiotic-associated diarrhea (AAD) in patients in the intensive care unit (ICU) receiving antifungals with the aim of informing rational antibiotic use. Methods Sex, age, medical history, use of proton pump inhibitors, administration of parenteral nutrition, albumin level, occurrence of AAD, type of antibiotics, duration of ICU admission, and prognosis were retrospectively analyzed. The associations of age, sex, medical history, and other factors with AAD were associated by logistic regression. Results In total, 284 patients were enrolled (antifungals, n = 110; no antifungals, n = 174). The total incidence of AAD was 32.39%. The incidence of AAD was significantly different between the groups (52.73% vs. 19.54%). The duration of proton pump inhibitor therapy, duration of antifungal therapy, enzyme inhibitor antibiotic use, and azithromycin use were associated with AAD in ICU patients receiving antifungal therapy. The mean duration of ICU admission was higher in patients receiving antifungal therapy (20.14 ± 11.50 vs. 14.48 ± 8.54 days). There was no significant difference in ICU mortality rates. Conclusion The duration of proton pump inhibitor therapy, duration of antifungal therapy, use of enzyme inhibitor antibiotics, and use of azithromycins were associated with AAD in ICU patients receiving antifungal therapy.

APA, Harvard, Vancouver, ISO, and other styles

2

Ramakrishnan, Meera. "Antibiotic stewardship - Rational use of antibiotics and antifungal agents." Journal of Pediatric Critical Care 2, no. 2 (2015): 50. http://dx.doi.org/10.21304/2015.0202.00067.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pasaribu, Tiurma. "PELUANG ZAT BIOAKTIF TANAMAN SEBAGAI ALTERNATIF IMBUHAN PAKAN ANTIBIOTIK PADA AYAM / The Opportunities of Plants Bioactive Compound as an Alternative of Antibiotic Feed additive on Chicken." Jurnal Penelitian dan Pengembangan Pertanian 38, no. 2 (2019): 96. http://dx.doi.org/10.21082/jp3.v38n2.2019.p96-104.

Full text

Abstract:

<p>Bioactive compounds (phenols, tannins, flavonoids, essential oils, curcumin, saponins, phyllanthin) have the ability as an antibacterial or antifungal. Feed additives are feed raw materials that do not contain nutrients, however, it may increase productivity, quality of livestock products (meat, eggs, milk, skin, feathers), the feed efficiency and to improve animal health or resistance of disease. Feed additives that are widely used in the livestock industry include antibiotics, antioxidants, antifungals, emulsifiers, and binders. The aim of using antibiotics is to reduce the population of pathogenic microbes or disturbing microbes in the digestive tract. Antibiotics have been banned for used because it can cause resistance to pathogenic bacteria or intestinal microflora which has a negative impact on consumers. To improve feed efficiency in poultry and to produce higher quality products, healthy and safe for consumption, the antibiotic could be replaced with plant bioactive compound. The aims of this review is to describe the role of plant bioactive compounds as feed additive to replace antibiotic for chickens. Some of plant bioactive substances that can be used as feed additives include phenols, curcumin, saponins, tannins, phenols, flavonoids, alkaloids. Bioactive substances from plants have several functions including inhibiting the growth of bacteria or fungi, increasing endurance, as an adjuvant, and preventing fat oxidation. It can be concluded that bioactive substances from plants have potential as feed additives which have the ability as antibacterial, antifungal, antioxidant, immunostimulator, and adjuvant.</p><p>Keywords: bioactive compound, plants, feed additives, chicken </p><p> </p><p><strong>Abstrak</strong></p><p> Zat bioaktif (fenol, tanin, flavonoid, minyak atsiri, curcumin, saponin, phyllanthin) memiliki kemampuan sebagai antibakteri atau antifungi. Imbuhan pakan adalah bahan baku pakan yang tidak mengandung nutrisi, namun dapat meningkatkan produktivitas, kualitas produk ternak (daging, telur, susu, kulit, bulu), efisiensi penggunaan pakan dan meningkatkan kesehatan hewan atau ketahanan terhadap penyakit. Imbuhan pakan yang banyak digunakan dalam industri peternakan termasuk antibiotik, antioksidan, antifungi, pengemulsi, dan pengikat (binder). Tujuan penggunaan antibiotik adalah untuk mengurangi populasi mikroba patogen atau mikroba yang mengganggu di saluran pencernaan. Antibiotik telah dilarang untuk digunakan karena dapat menyebabkan resistensi terhadap bakteri patogen atau mikroflora usus yang memiliki dampak negatif pada konsumen. Untuk meningkatkan efisiensi pakan pada unggas dan menghasilkan produk berkualitas tinggi, sehat dan aman untuk dikonsumsi, antibiotik dapat diganti dengan zat bioaktif tanaman. Tujuan dari ulasan ini adalah untuk menggambarkan peran zat bioaktif tanaman sebagai pengganti imbuhan pakan antibiotik pada ayam. Beberapa zat bioaktif tanaman yang dapat digunakan sebagai imbuhan pakan termasuk fenol, kurkumin, saponin, tanin, fenol, flavonoid, alkaloid. Zat bioaktif dari tanaman memiliki beberapa fungsi antara lain menghambat pertumbuhan bakteri atau jamur, meningkatkan daya tahan tubuh, sebagai bahan adjuvan dan mencegah oksidasi lemak. Dapat disimpulkan bahwa zat bioaktif dari tanaman berpotensi sebagai imbuhan pakan yang memiliki kemampuan sebagai antibakteri, antifungi, antioksidan, imunostimulator, dan adjuvant.</p><p>Kata kunci: Zat bioaktif, tanaman, imbuhan pakan, ayam </p>

APA, Harvard, Vancouver, ISO, and other styles

4

ROY, SWAPAN KUMAR, SHOSHIRO NAKAMURA, JUN FURUKAWA, and SHIGENOBU OKUDA. "The structure of neo-enactin A, a new antifungal antibiotic potentiating polyene antifungal antibiotics." Journal of Antibiotics 39, no. 5 (1986): 717–20. http://dx.doi.org/10.7164/antibiotics.39.717.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hwang, Byung Kook, Sang Joon Ahn, and Surk Sik Moon. "Production, purification, and antifungal activity of the antibiotic nucleoside, tubercidin, produced by Streptomyces violaceoniger." Canadian Journal of Botany 72, no. 4 (1994): 480–85. http://dx.doi.org/10.1139/b94-064.

Full text

Abstract:

Three antibiotic substances strongly inhibitory to Phytophthora capsici or Magnaporthe grisea were isolated from the broth culture of Streptomyces violaceoniger strain A50. A butanol-soluble mixture of antibiotics from the broth were partially purified by XAD-2 column chromatography. The XAD-2 eluates inhibited the mycelial growth of P. capsici and M. grisea and the development of Phytophthora blight on pepper (Capsicum annuum L.) plants. The antibiotics were separated by silica gel column chromatography and then purified on a Sephadex LH-20 column to yield three peaks of antifungal activity: SF1A, SF1B, and SF2A. The pure antibiotic SF2A was further purified by preparative HPLC and identified as the pyrrolo[2,3-d]-pyrimidine nucleoside tubercidin based on the UV, 1H, and 13C NMR spectral data and other chemical evidence. The antibiotic SF2A and authentic tubercidin showed a high antifungal activity against the plant pathogenic fungi P. capsici, Botryosphaeria dothidea, and Rhizoctonia solani. Key words: Streptomyces violaceoniger, tubercidin, antifungal activity.

APA, Harvard, Vancouver, ISO, and other styles

6

OKI, TOSHIKAZU, KYOICHIRO SAITOH, KOZO TOMATSU, KOJI TOMITA, MASATAKA KONISHI, and HIROSHI KAWAGUCHI. "Novel Antifungal Antibiotic BMY-28567." Annals of the New York Academy of Sciences 544, no. 1 Antifungal Dr (1988): 184–87. http://dx.doi.org/10.1111/j.1749-6632.1988.tb40402.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

ANDO, OSAMU, HITOMI SATAKE, MUTSUO NAKAJIMA, et al. "Synerazol, a new antifungal antibiotic." Journal of Antibiotics 44, no. 4 (1991): 382–89. http://dx.doi.org/10.7164/antibiotics.44.382.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Pawar, Kajal, Rutuja Gadhave, Swati Waydande, and Pravin Pawar. "Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications." Drug Delivery Letters 9, no. 3 (2019): 199–210. http://dx.doi.org/10.2174/2210303109666190508082009.

Full text

Abstract:

Background & Objectives: Fungi are the heterotrophic eukaryotic organisms which are useful as they causes the biodegradation. There are still some harmful species like yeasts, molds and dermatophytes which cause the infections. As the fungi are eukaryotics, they do not respond to the antibiotic therapy due to the limitations associated with the traditional antibiotic therapies. There are several antifungal agents introduced to treat such infections. These antifungal agents posses severe problems like drug resistance and toxicity due to the higher dose which comprises the need for newer alternatives over conventional dosage forms. Novel drug delivery systems proved to be a better approach to enhance the effectiveness of the antifungals and enhance patient compliance by reducing the adverse effect. Discussion: This review focused on the general information about fungal infections, types and mechanism of action of antifungal agents and overview of formulation approaches such as vesicular system, colloidal system, nanoparticulate system and in situ gelling which are often studied for antifungal treatments. Conclusion: We concluded that the novel drug delivery systems are the essential techniques for delivering the antifungal agents to their target site with desired concentration. Moreover, the researchers focused on these novel drug deliveries which mainly concentrate on controlling & sustaining the release of antifungal agents.

APA, Harvard, Vancouver, ISO, and other styles

9

Dubin, Marc G., Cindy Liu, Sandra Y. Lin, and Brent A. Senior. "American Rhinologic Society Member Survey on “Maximal Medical Therapy” for Chronic Rhinosinusitis." American Journal of Rhinology 21, no. 4 (2007): 483–88. http://dx.doi.org/10.2500/ajr.2007.21.3047.

Full text

Abstract:

Background “Maximal medical therapy” is the standard of care for chronic rhinosinusitis (CRS) treatment before the recommendation for surgery. However, this therapy is not consistent. Therefore, as a first step in determining the role of the disparate “maximal medical” treatments for CRS, American Rhinologic Society (ARS) members were surveyed. Methods A survey was mailed to all nonresident members of the ARS (n = 723). Focusing on the time period before surgical intervention is first considered for CRS patients, the survey assessed types of therapies, frequency of use, details on antibiotic and steroid usage, use of computed tomography (CT), and demographic data of respondents. All responses were anonymous. Results Three hundred eight surveys were returned (43%). A majority of respondents used oral antibiotics and nasal steroids “almost always (>90%).” Oral antibiotics, oral steroids, nasal steroids, saline irrigation, and allergy testing were most commonly used at least “usually (50–90%).” The median antibiotic length was 3.1–4 weeks. The mean peak prednisone dose was 51.7 mg when oral steroids were used. Therapies that were rarely or never used by the majority included oral antifungals, antifungal spray, antibiotic spray, antibiotic nebulizer, steroid nebulizer, and i.v. antibiotics. Conclusion Oral antibiotics (median, 3.1–4 weeks) and nasal steroids are used >90% of the time by a majority of ARS members for maximal medical treatment of CRS.

APA, Harvard, Vancouver, ISO, and other styles

10

URAMOTO, MASAKAZU, YIN-CHU SHEN, NAOMI TAKIZAWA, HIROO KUSAKABE, and KIYOSHI ISONO. "A new antifungal antibiotic, phosphazomycin A." Journal of Antibiotics 38, no. 5 (1985): 665–68. http://dx.doi.org/10.7164/antibiotics.38.665.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Antifungal antibiotic"

1

Chan, Tsui Fen. "Studies towards the total synthesis of ambruticin." Thesis, University of Salford, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.244865.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Nedal, Aina. "Post-PKS modifications in the biosynthesis of the antifungal antibiotic nystatin." Doctoral thesis, Norwegian University of Science and Technology, Department of Biotechnology, 2007. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-1581.

Full text

Abstract:

<p>The antifungal polyene macrolide nystatin is produced by <i>Streptomyces noursei</i> ATCC 11455. The nystatin biosynthesis gene cluster of <i>Streptomyces noursei</i> has been cloned and sequenced, and a biosynthesis route has been predicted. In the present work, investigation of genes presumably involved in post-PKS modifications of nystatin is described. The aim of this work was to better understand the nystatin biosynthesis and to further use this information for generation of novel nystatin analogues. Two PKS-modifications of the nystatin molecule were targeted in this study: glycosylation with mycosamine at C-19 and oxidation of the exocyclic methyl group at C-16.</p><p>Two genes putatively involved in mycosamine biosynthesis (<i>NysDIII</i> and <i>NysDII</i>) and one in attachment of mycosamine to the nystatin aglycone (<i>nysDI</i>) have been identified in the nystatin gene cluster. Their functions have been suggested, respectively, as a putative mannose dehydratase, aminotransferase and a glycosyltransferase. The deoxysugar mycosamine is proposed to have an important function for the activity of nystatin. To better understand the biosynthesis and importance of mycosamine and to perform modifications of nystatin via this post-PKS modifying step, the mycosamine biosynthesis was studied. The NysDIII protein was overexpressed in <i>Escherichia coli </i>and purified, and its <i>in vitro</i> mannose 4,6-dehydratase activity was confirmed. To study the function of <i>nysDII</i> and <i>nysDI</i>, the genes were individually deleted from the <i>S. noursei</i> chromosome. Both mutants were shown to produce a mixture of nystatinolide and 10-deoxynystatinolide, albeit at considerably different levels. Complementation experiments unequivocally confirmed the involvement of these two in mycosamine biosynthesis and attachement. Both antifungal and hemolytic activity of the purified nystatinolides were tested, and were found to be strongly reduced compared to nystatin, confirming the importance of the mycosamine moiety for the biological activity of nystatin.</p><p>A gene for putative P450 monooxyganse NysN has been identified in the nystatin biosynthesis gene cluster. The function of NysN has been predicted to be oxidation of an exocyclic C16 methyl group on the nystatin molecule in order to afford a C16 carboxyl. The latter group has been implicated in selective toxicity of other polyene macrolides, and thus is considered an important target for manipulation. The <i>nysN</i>gene was inactivated in S. noursei by both in-frame deletion and site-specific mutagenesis, and the resulting mutants were shown to produce 16-decarboxy-16-methylnystatin, supporting the suggested biological role of NysN as C16 methyl oxidase. The recombinant NysN protein was also expressed in <i>Escherichia coli</i>, but its C16-methyl oxidase activity in vitro could not be demonstrated. 16-decarboxy-16-methylnystatin was purified from the nysN mutant, and its antifungal activity was identical with nystatin whereby the toxicit was reduced compared to nystatin.</p><p>In the work of developing new methods for obtaining nystatin analogues, bioconversion of nystatinolide was performed as a means to modify nystatin aglycone. For this purpose a sub-library of 35 different <i>Streptomyces</i> strains isolated from the Trondheims fjord was selected. One strain was shown to be able to add a water molecule (presumed epoxidation) and another strain was able to chlorinate the nystatinolides. An attempt on alternative glycosylation of nystatinolide was performed by using glycosyltransferase hybrids and deoxysugar biosynthesis gene cassettes. However, these experiments did not afford novel nystatin analogues, suggesting strong preference of the NysDI glycosyltyransferase for its natural sugar substrate GDP-mycosamine.</p>

APA, Harvard, Vancouver, ISO, and other styles

3

Beatty, Perrin. "Investigations of an antifungal antibiotic produced by an environmental isolate of Paenibacillus polymyxa." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape2/PQDD_0014/NQ59930.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Suloff, Eric Charles. "Comparative Study of Semisynthetic Derivative of Natamycin and the Parent Antibiotic on the Spoilage of Shredded Cheddar Cheese." Thesis, Virginia Tech, 1999. http://hdl.handle.net/10919/35937.

Full text

Abstract:

The polyene macrolide antibiotic natamycin (Antibiotic A-5283) is commonly used to retard the growth of surface molds on various cheese varieties. Natamycin is commonly applied to the surface of cheese by dipping or spraying, using an aqueous dispersion containing 200 to 300 ppm of the additive. The large molecular weight of natamycin, 666 g/mol, and conjugated double bond structure causes it to be extremely insoluble in water and most food grade solvents. The inability to apply natamycin in true solution creates void non-treated areas on the food surface. These non-treated areas promote the growth of fungal organisms. A water soluble N-alkyl semisynthetic derivative of natamycin was synthesized by the Michael addition reaction of the parent with a N-substituted malemide. A comparative study investigating the effectiveness of the semisynthetic derivative of natamycin and the parent antibiotic in suppressing mold growth on one month aged shredded Cheddar cheese modified atmosphere packaged (MAP) was performed. A 20 ppm natamycin treatment effectively suppressed visible mold growth (<104 CFU/g) in MAP samples for up to 30 days after opening. The 20 ppm semisynthetic derivative performed similarly to the 10 ppm natamycin treatment in retarding mold growth. Visible mold growth did not occur for these treatments in MAP samples until 20 days after opening. Analysis of storage conditions revealed that an outgrowth of mold in shredded cheese occurred in MAP packages stored longer than 15 days. This bloom in mold growth was attributed to the degradation of natamycin and the semisynthetic derivative throughout storage. The stability and degradation of natamycin and the derivative were monitored throughout the study. Antibiotic concentration on the cheese surface was quantified by molecular absorption spectrometry. Results from this study showed, heavily contaminated samples caused the rate and loss of natamycin and the derivative to increase. Antibiotic concentration decreased at a similar rate in MAP and open package conditions. Natamycin and derivative were found to have similar degradation properties.<br>Master of Science

APA, Harvard, Vancouver, ISO, and other styles

5

Pereira, Marie Antoinette Tanya. "Cellular differentiation and antibiotic production by Streptomyces nodosus immobilised in alginate capsules." View thesis, 2007. http://handle.uws.edu.au:8081/1959.7/20504.

Full text

Abstract:

Thesis (PhD) -- University of Western Sydney, 2007.<br>A thesis submitted to the University of Western Sydney, College of Health and Science, School of Natural Sciences, as a requirement for the degree of Doctor of Philosophy. Includes bibliography.

APA, Harvard, Vancouver, ISO, and other styles

6

Heldreth, Bart Allan. "N-Thiolated β-Lactams: Chemistry, SAR and Intracellular Target of a Novel Class of Antimicrobial and Anticancer Agents". Scholar Commons, 2004. https://scholarcommons.usf.edu/etd/1074.

Full text

Abstract:

N-Thiolated β-lactams (1) represent a promising new group of compounds with potent inhibition effects on bacteria, like Bacillus anthracis and methicillin resistant Staphylococcus aureus, and onco-systems, like breast cancer and leukemia. Originally developed as part of a synthetic pathway to bicyclic lactams, N-thiolated β-lactams have been shown in this laboratory to possess intriguing biological activities. The antibacterial activities of this new class of agents rely on novel structural features unlike those of any existing family of β-lactam drugs. The lactams seem to exert their effects intracellularly, requiring passage of the bioactive species through the cellular membrane, rather than acting extracellularly on cell wall components in the manner of penicillin and related antibiotics. The lipophilic nature of these molecules, which lack the polar side chain functionality of all other microbially-active β-lactams, suggests the compounds do not target the penicillin binding proteins within bacterial membranes but instead pass through these membranes. The biological target of these compounds has been investigated. The most active members of this β-lactam class appear to be those bearing a small branched alkyl chain on the sulfur atom. The effects of stereochemistry, branching and chain length of the sulfur group on bioactivities were studied. This dissertation is divided into six chapters. A review of organosulfur anti-infectives is discussed in Chapter 1. The types of existing antibiotics and their modes of action will be discussed in Chapter 2. The synthesis of these novel agents is discussed in Chapter 3. A structure-activity relationship of these lactam analogues is discussed in Chapter 4. And Chapters 5 and 6 demonstrate a novel mode of action and biological target for these drugs using techniques which include target identification, metabolic effects, and reactivity kinetics.

APA, Harvard, Vancouver, ISO, and other styles

7

Pohanka, Anton. "Antifungal antibiotics from potential biocontrol microorganisms /." Uppsala : Department of Chemistry, Swedish University of Agricultural Sciences, 2006. http://epsilon.slu.se/200647.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sekole, M. J. "The Use of antibiotics post- tonsillectomy at Dr George Mukhari Hospital (DGMH): Is it of benefit ?" Thesis, University of Limpopo (Medunsa Campus), 2011. http://hdl.handle.net/10386/666.

Full text

Abstract:

Thesis (M Med (Otorhinolaryngology))-- University of Limpopo, 2011.<br>Aims: The purpose of this study was to assess if the use of post-operative antibiotics have any beneficial effects in reducing morbidity following elective tonsillectomy in children with age range of 1-13 years. . Objectives: To assess the degree of post-tonsillectomy pain, determine the incidence of secondary haemorrhage, establish the time period to the resumption of a normal diet, document adverse effects of the use of antibiotics (e.g. skin rash, anaphylaxis, diarrhoea and vomiting), determine the bacteriology in tonsil removed and make recommendations on post-tonsillectomy treatment protocol at DGMH. Methods: This prospective study was conducted at DGMH on 81 children with an age range of l-13years (mean 5.7years). At total of 40 children received paracetamol l5mg/kg/day (Group A) in three divided doses for seven days, and 41 received amoxicillin 40 mg/kg/day and paracetamol (Group B) for the same duration. The post operative morbidity and bacteriology of the two treatment groups were compared. Primary outcomes measured included the incidence and severity of pain, use of analgesia, resumption of normal diet, incidence ofheamorrhage, fever, vomiting and adverse reactions.

APA, Harvard, Vancouver, ISO, and other styles

9

Shallow, David A. "Peptide transport in Candida albicans and synthetic antifungal agents." Thesis, Durham University, 1986. http://etheses.dur.ac.uk/6890/.

Full text

Abstract:

These studies have characterized the peptide transport systems of Candida albicans, with a view to the rational design of peptide antifungal agents exploiting the 'smugglin' concept. In initial studies, a series of polyoxin complexes (peptide-nucleoside antibiotics) and individual components, were isolated from a batch of agricultural fungicide (Polyoxin Z). Isolated fractions were toxic to a particulate chitin synthetase preparation from Candida albicans. Different strains of Candida albicans exhibited varied sensitivities to a series of peptide analogues. From a sensitive strain, B2630, spontaneous mutants were selected for resistance to each analogue; certain mutants showed cross-resistance to other analogues and associated defects in peptide transport. A bacilysin-resistant mutant was cross-resistant to the other analogues and to m- fluorophenylalanylalanylalanine a but retained sensitivity to m- fluorophenylalanylalanylalanine. This mutant showed defective dipeptide transport but normal oligopeptide transport, and was unable to utilize Ala-Ala as a sole nitrogen source. Thus, Candida albicans has distinguishable mechanisms for dipeptide and oligopeptide transport which can be exploited for uptake of peptide-drug adducts. Peptide transport was shown to be stimulated by the presence of peptides (peptone) in the growth medium. On transferring cells from minimal to peptone medium, this stimulatory effect was shown to be rapid, independent of protein synthesis and to override ammonia regulation of peptide transport. The reduction of transport activity on transferring cells from peptone to minimal medium was also rapid. It was speculated that regulation of peptide transport is achieved by a rapid, reversible activation of preformed transport components, or a mechanism of exocytotic insertion and endocytic retrieval of preformed transporters. The effect of protein-modification reagents on transport activity was also examined. Dipeptide transport was specifically inhibited by N-ethyl-5-phenylisoxazolium-3'-sulphonate (Woodwards Reagent K), offerring potential for the specific labelling of the component(s) of this system. Peptide transport was shown not to be sensitive to osmotic shock though a series of uncharacterized polypeptides was released by the shock treatment.

APA, Harvard, Vancouver, ISO, and other styles

10

Daoud, N. N. "Isolation and characterization of antifungal antibiotics synthesized by Myxococcus spp." Thesis, University of Salford, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.376848.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Antifungal antibiotic"

1

Ólafsson, Jón Hjaltalín, and Roderick James Hay, eds. Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chipeleme, Alex. Synthetic studies on the antifungal antibiotic-ambruticin. University of Salford, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Grayson, M. Lindsay. Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs : Antibiotics. Hodder Arnold, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

International, Telesymposium on Recent Trends in the Discovery Development and Evaluation of Antifungal Agents (1987). Recent trends in the discovery, development and evaluation of antifungal agents: Proceedings of an international telesymposium, May 1987. J.R. Prous Science, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

A, Hunter P., Darby G. K, and Russell Nicholas J, eds. Fifty years of antimicrobials: Past perspectives and future trends : Fifty-third Symposium of the Society for General Microbiology held at the University of Bath April 1995. Cambridge University Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ólafsson, Jón Hjaltalín, and Roderick James Hay. Antibiotic and Antifungal Therapies in Dermatology. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Whitney, Laura, and Tihana Bicanic. Antifungal stewardship. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198758792.003.0016.

Full text

Abstract:

Although the principles of antifungal stewardship are similar to those of antibiotic stewardship, there are a number of key differences, as outlined in this chapter. Antifungal prescribing occupies a specialist niche: it occurs much less frequently than antibacterial prescribing due to the smaller, but increasing, population at risk of fungal infection. Antifungal stewardship is thus less established compared with programmes directed at antibacterials, with a narrower and more complex evidence base. This chapter provides examples of successful stewardship programmes in different settings, allowing readers to understand the challenges of antifungal stewardship and how to address these and enabling them to build a successful stewardship programme at their own institution.

APA, Harvard, Vancouver, ISO, and other styles

8

A, Kucers, ed. The use of antibiotics: A clinical review of antibacterial, antifungal, and antiviral drugs. 5th ed. Butterworth-Heinemann, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kucers, A., S. M. Crowe, M. L. Grayson, and J. F. Hoy. The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs. 5th ed. A Hodder Arnold Publication, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

A, Sutcliffe Joyce, and Georgopapadakou Nafsika H. 1950-, eds. Emerging targets in antibacterial and antifungal chemotherapy. Chapman and Hall, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Antifungal antibiotic"

1

Odds, Frank C. "Antifungal Agents: Resistance and Rational Use." In Antibiotic Policies. Springer US, 2005. http://dx.doi.org/10.1007/0-387-22852-7_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sigurgeirsson, Bárður, and Roderick J. Hay. "The Antifungal Drugs Used in Skin Disease." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ingen-Housz-Oro, S., P. Del Giudice, and O. Chosidow. "Common Skin Bacterial Infections." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sigurgeirsson, Bárður. "Onychomycosis." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

van Hees, Colette L. M., and Ben Naafs. "Cutaneous Leishmaniasis." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Layton, Alison M. "Antibiotics in the Management of Acne." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Zouboulis, Christos C., Martin Schaller, and Harald P. M. Gollnick. "Antimicrobial Treatment of Rosacea." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Tschachler, Erwin, and George-Sorin Tiplica. "Venereal Disease I: Syphilis." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Tiplica, George-Sorin, and Erwin Tschachler. "Venereal Disease II: Chlamydia trachomatis Infection, Gonorrhoea." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Naafs, Bernard, Colette L. M. van Hees, and Jakko van Ingen. "Mycobacterial (Skin) Infections." In Antibiotic and Antifungal Therapies in Dermatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39424-4_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Antifungal antibiotic"

1

Bagiński, Maciej, Pierluigi Gariboldi, and Edward Borowski. "The distribution of molecular electrostatic potential for antifungal antibiotic amphotericin B." In The first European conference on computational chemistry (E.C.C.C.1). AIP, 1995. http://dx.doi.org/10.1063/1.47829.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sarvarova, E. R., E. A. Cherepanova, and I. V. Maksimov. "Antifungal activity of lipopeptides from endophytic strains of the genus Bacillus sp. against the fungus Stagonospora nodorum (Berk.)." In 2nd International Scientific Conference "Plants and Microbes: the Future of Biotechnology". PLAMIC2020 Organizing committee, 2020. http://dx.doi.org/10.28983/plamic2020.216.

Full text

Abstract:

The direct antibiotic effect of lipopeptides from four endophytic strains on the germination of spores of the pathogenic fungus Stagonospora nodorum (Berk.) was found and the minimum inhibitory concentration (MIC) of these lipopeptides was determined.

APA, Harvard, Vancouver, ISO, and other styles

3

Yang, Ning, Yong Wang, Yu-Bo Wang, et al. "Screen of Chryseobacterium CHANGBAI-2 strain and Identification of the Antifungal Antibiotic from Its Fermentation Broth." In 2017 2nd International Conference on Biological Sciences and Technology (BST 2017). Atlantis Press, 2018. http://dx.doi.org/10.2991/bst-17.2018.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Popovici, Violeta, Laura Bucur, Gabriela Vochita, Victoria Badea, and Florin-Ciprian Badea. "CONTRIBUTIONS TO THE COMPLEX STUDY ON ANTITUMOR ACTIVITY OF USNEA BARBATA (L.) F.H.WIGG." In NORDSCI International Conference. SAIMA Consult Ltd, 2020. http://dx.doi.org/10.32008/nordsci2020/b1/v3/25.

Full text

Abstract:

Usnea barbata (L.)F.H.Wigg. - known as “old man’s beard”, “tree moss”, “songluo” is a lichen in the family Parmeliaceae, genus Usnea. Usnea species have recorded history of therapeutic use dating back over three thousand years in Chinese medicine. The lichen secondary metabolites have shown an impressive range of biological proprieties, including antibiotic, antifungal, antiviral, anti-inflammatory, or anticancer activities. In this study, the antitumor activity of Usnea barbata extract was evaluated by observing the morphological changes on squamous cells carcinoma cell-line CAL 27 (ATCC® CRL-2095 ™) in contact with different concentrations of extract, ranged between 12.5–400 μg/mL. The results obtained were quantified by the intensity of morphological changes of the tumor cells after 24 hours of contact. The most significant activity were recorded for 400 μg/mL extract. This study shows that Usnea barbata (L.)F.H.Wigg. extract has antitumor activity. The analysis of the obtained results showed that the cytotoxicity of lichen extract on CAL 27 tumor cells is directly related to the concentration of the applied solution.

APA, Harvard, Vancouver, ISO, and other styles

5

Olkiewicz, Katarzyna, Anna Łegowska, Natalia Ptaszynska, et al. "Peptide conjugates of transportan10 with antimicrobial and antifungal antibiotics." In 35th European Peptide Symposium. Prompt Scientific Publishing, 2018. http://dx.doi.org/10.17952/35eps.2018.309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Eloff, J., C. van Wyk, T. Ramadwa, F. Botha, and Z. Apostolides. "Can obliquumol isolated from Ptaeroxylon obliquum be a new framework molecule for future antifungal antibiotics?" In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608330.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Solal, A., C. Bouchand, A. Guerin, M. Postaire, S. Cisternino, and F. Moulin. "4CPS-224 Evaluation of systemic antibiotics and antifungal use in an intensive paediatric care unit: a five-year study in a french university hospital." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!